ASARFI CANCER INSTITUTE PRIVATE LIMITED
ASARFI CANCER INSTITUTE PRIVATE LIMITED is a JHARKHAND based PRIVATE LIMITED company, Registered at dated 06-FEB-2020 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of ASARFI CANCER INSTITUTE PRIVATE LIMITED is U85300JH2020PTC014046 and registration number is 014046.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies ROC-JHARKHAND India. Authorized share capital of ASARFI CANCER INSTITUTE PRIVATE LIMITED is Rs. 1000000 and its paid up capital is Rs. 100000. It aspire to serve in HEALTH AND SOCIAL WORK activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on .
ASARFI CANCER INSTITUTE PRIVATE LIMITED has 2 directors UDAI PRATAP SINGH, MADHURI SINGH,
The registered Email address of ASARFI CANCER INSTITUTE PRIVATE LIMITED is asarficancerinstitute@outlook.com and its registered address is 570 P, RANGUNI,BHULI,354 P.S BASURIYA DHANBAD DHANBAD JH 828104 IN JHARKHAND JHARKHAND india 828104.
The current status of ASARFI CANCER INSTITUTE PRIVATE LIMITED shows as ACTIVE
COMPANY BASIC DETAILS
ASARFI CANCER INSTITUTE PRIVATE LIMITED
ROC-JHARKHAND
ACTIVE
HEALTH AND SOCIAL WORK
U85300JH2020PTC014046
06-FEB-2020
COMPANY LIMITED BY SHARES
NON-GOVT COMPANY
PRIVATE
1000000
100000
CONTACT DETAILS
828104
INDIA
570 P, RANGUNI,BHULI,354 P.S BASURIYA DHANBAD DHANBAD JH 828104 IN
asarficancerinstitute@outlook.com
DIRECTOR DETAILS
DIN | Director Name | Designation | Appointment Date |
---|---|---|---|
08453794 | UDAI PRATAP SINGH | Director | 06/02/2020 |
06562038 | MADHURI SINGH | Director | 06/02/2020 |
Details Updated by Companies
Quick Links
- All Registered company of JHARKHAND
- Company Registered in JHARKHAND
- All Registered company of DHANBAD in JHARKHAND
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.